Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 15/20 | 0.83 |
| ▸ | RAB9A | P51151 | 15/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 10/20 | 0.83 |
| ▸ | HPGD | P15428 | 5/20 | 0.83 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.83 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.83 |
| ▸ | RELA | Q04206 | 2/20 | 0.83 |
| ▸ | POLB | P06746 | 1/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.66 |
| ▸ | TSHR | P16473 | 2/20 | 0.66 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | GAA | P10253 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6015198 | 1.00 | NPC1 (0.83) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL13231671 | 0.97 | NPC1 (0.79) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL12918681 | 0.93 | NPC1 (0.73) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL10330356 | 0.91 | NPC1 (0.70) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL762284 | 0.91 | NPC1 (1.00) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL14818889 | 0.91 | NPC1 (1.00) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL12354772 | 0.91 | NPC1 (0.70) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL13231654 | 0.89 | NPC1 (0.68) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL21673239 | 0.89 | NPC1 (0.96) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 | |
| SCHEMBL19010395 | 0.89 | NPC1 (0.79) | NPC1RAB9ASMN1; SMN2HPGDNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060255322-A1 | Methods and compositions for improved electrophoretic display performance | WU ZARNG-ARH G | 2006-11-16 | — | — | US | claimed |
| EP-1529242-A2 | PROTECTING LAYER WITH ADDITIVES FOR ELECTROPHORETIC DISPLAY, METHOD OF PROVIDING SUCH LAYER, AND ELECTROPHORETIC DISPLAY WITH SUCH A LAYER | Sipix Imaging, Inc. (US) | 2005-05-11 | — | — | EP | claimed |
| US-20040085619-A1 | Novel Methods and compositions for improved electrophoretic display performance | SIPIX IMAGING, INC. | 2004-05-06 | — | — | US | claimed |
| WO-2004010206-A2 | PROTECTING LAYER WITH ADDITIVES FOR ELECTROPHORETIC DISPLAY, METHOD OF PROVIDING SUCH LAYER, AND ELECTROPHORETIC DISPLAY WITH SUCH A LAYER | SIPIX IMAGING, INC. (US) | 2004-01-29 | — | — | WO | claimed |
| US-20220216422-A1 | Electroluminescent Device | UDC IRELAND LTD (IE) | 2022-07-07 | — | — | US | disclosed |
| US-11217752-B2 | Diketopyrrolopyrrole polymers as organic semiconductors | BASF SE (DE) | 2022-01-04 | — | — | US | disclosed |
| WO-2021017214-A1 | ELECTROLUMINESCENT POLYMER, PREPARATION METHOD AND APPLICATION THEREOF | 华南理工大学 | 2021-02-04 | — | — | WO | disclosed |
| WO-2020158795-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM USING SAME, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2020-08-06 | — | — | WO | disclosed |
| US-10431745-B2 | Diketopyrrolopyrrole polymers for use in organic field effect transistors | BASF SE (DE) | 2019-10-01 | — | — | US | disclosed |
| US-10424737-B2 | Diketopyrrolopyrrole polymers as organic semiconductors | BASF SE (DE) | 2019-09-24 | — | — | US | disclosed |
| EP-2518111-B1 | COMPOSITION AND LUMINESCENT ELEMENT OBTAINED USING SAME | SUMITOMO CHEMICAL CO (JP) | 2019-03-13 | — | — | EP | disclosed |
| US-10224484-B2 | Diketopyrrolopyrrole polymers for use in organic field effect transistors | BASF SE (DE) | 2019-03-05 | — | — | US | disclosed |
| US-20060036097-A1 | Oxadiazole metallic complexes and their electronic and opto-electronic applications | MERCK PATENT GMBH (DE) | 2006-02-16 | — | — | US | disclosed |
| EP-1529242-A2 | PROTECTING LAYER WITH ADDITIVES FOR ELECTROPHORETIC DISPLAY, METHOD OF PROVIDING SUCH LAYER, AND ELECTROPHORETIC DISPLAY WITH SUCH A LAYER | Sipix Imaging, Inc. (US) | 2005-05-11 | — | — | EP | disclosed |
| US-20050007648-A1 | Methods and compositions for improved electrophoretic display performance | E INK CORPORATION | 2005-01-13 | — | — | US | disclosed |
| US-20040085619-A1 | Novel Methods and compositions for improved electrophoretic display performance | SIPIX IMAGING, INC. | 2004-05-06 | — | — | US | disclosed |
| WO-2004010206-A2 | PROTECTING LAYER WITH ADDITIVES FOR ELECTROPHORETIC DISPLAY, METHOD OF PROVIDING SUCH LAYER, AND ELECTROPHORETIC DISPLAY WITH SUCH A LAYER | SIPIX IMAGING, INC. (US) | 2004-01-29 | — | — | WO | disclosed |
| EP-1075497-A1 | POLYMERS CONTAINING OPTICAL BRIGHTENER COMPOUNDS COPOLYMERIZED THEREIN AND METHODS OF MAKING AND USING THEREFOR | EASTMAN CHEMICAL COMPANY (US) | 2001-02-14 | — | — | EP | disclosed |
| US-6150494-A | POLYESTERS WITH AMIDES OR SULFONATES FOR OPTICAL BRIGHTENERS | EASTMAN CHEMICAL COMPANY (US) | 2000-11-21 | — | — | US | disclosed |
| WO-1999055761-A1 | POLYMERS CONTAINING OPTICAL BRIGHTENER COMPOUNDS COPOLYMERIZED THEREIN AND METHODS OF MAKING AND USING THEREFOR | EASTMAN CHEMICAL COMPANY (US) | 1999-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060036097-A1 | Oxadiazole metallic complexes and their electronic and opto-electronic applications | OXA1L, PPOX, MT-CO3 | NPC1 3772/4885RAB9A 4032/4885SMN1; SMN2 3817/4885 |
| US-20220216422-A1 | Electroluminescent Device | PNPO, ODC1, AXL | NPC1 4737/4885RAB9A 2872/4885SMN1; SMN2 2385/4885 |
| US-10424737-B2 | Diketopyrrolopyrrole polymers as organic semiconductors | PIN1, PPOX, DDT | NPC1 4043/4885RAB9A 1829/4885SMN1; SMN2 3951/4885 |
| US-11217752-B2 | Diketopyrrolopyrrole polymers as organic semiconductors | ARPC4, DRD1, DRD4 | NPC1 4672/4885RAB9A 3955/4885SMN1; SMN2 2988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.